Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2

NCT03192722•Nova Southeastern University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Ocular Conditions Resulting in Visual Impairment

Interventions

Colored near reading glasses

Lighting as determined by LuxIQ/2 or OttLite Cobra

Locations

United States

Locations (1)

Nova Southeastern University

Fort Lauderdale, Florida, United States

Key Dates

Start Date

April 20, 2017

Primary Completion Date

May 31, 2023

Completion Date

May 31, 2023

Last Updated

March 29, 2024

Sponsors

Lead Sponsor

Nova Southeastern University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 29, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions